Back to search

University of British Columbia

Metoprolol and cardiac carnitine palmitoyltransferase-1 : unravelling a complex interaction in normal and diabetic hearts

Abstract

dc:description

Diabetic cardiomyopathy may be initiated or compounded by the heavy reliance of the heart on fatty acids and ketones as metabolic fuels. β-blockers have been proposed to inhibit fatty acid oxidation by decreasing the activity of the enzyme carnitine palmitoyltransferase-1 (CPT-1). By inhibiting fatty acid oxidation, β-blockers could improve myocardial efficiency and ameliorate the cytoplasmic accumulation of toxic fatty acid and glucose intermediates. In this study, we investigated whether metoprolol improves cardiac function and inhibits fatty acid oxidation in the streptozotocin (STZ) diabetic rat, a model of poorly controlled type 1 diabetes. The animals were injected with 60 mg/kg STZ and were euthanized six weeks following the induction of diabetes. We investigated the effects of chronic metoprolol treatment (75 mg/kg/day), and acute metoprolol perfusion on cardiac function, substrate utilization and three major systems of CPT-1 regulation: malonyl CoA levels, CPT-1 transcription and covalent modifications (phosphorylation, nitrosylation, glutathiolation, nitration). Chronic metoprolol treatment improved cardiac function in the diabetic heart. Whereas, chronic metoprolol treatment increased fatty acid oxidation in control hearts but decreased it in diabetic hearts, acute metoprolol perfusion always inhibited fatty acid oxidation. Metoprolol lowered malonyl CoA levels in control hearts, and both acute metoprolol perfusion and chronic metoprolol treatment led to decreased CPT-1 maximum activity and decreased CPT-1 malonyl CoA sensitivity. CPT-1 sensitivity was increased by calcium/calmodulin-dependent protein kinase phosphorylation and decreased by protein kinase A-dependent phosphorylation in vitro. CPT-1 activity was inhibited by nitrosylation and glutathiolation, and stimulated by nitration in vitro. Chronic metoprolol treatment decreased the binding and coactivation of peroxisome-proliferator receptor-γ coactivator 1-α (PGC-1α) and peroxisome-proliferator receptor-α (PPAR-α), and also increased the binding of the repressor protein upstream stimulatory factor-2 (USF-2). In conclusion, metoprolol inhibited fatty acid oxidation, and acted partly by regulating malonyl CoA levels and partly by modulating the activity and malonyl CoA sensitivity of CPT-1 itself. The effects of metoprolol on CPT-1 were mediated acutely by covalent modifications and chronically by inhibition of the transcriptional complex that induces CPT-1 expression.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Pharmaceutical Sciences
Grantor dc:publisher
University of British Columbia
Year dc:date
2007

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Sharma, Vijay

Rights

dc:rights
Statement dc:rights
  • For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/31489

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Sharma, Vijay. Metoprolol and cardiac carnitine palmitoyltransferase-1 : unravelling a complex interaction in normal and diabetic hearts. doctoral thesis, University of British Columbia, 2007. http://hdl.handle.net/2429/31489